Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index

2006169 citationsJournal Article

Authors

P Jalava · University of Turku

Teijo Kuopio · Central Finland Health Care District

Laura Juntti-Patinen · University of Turku

Tero Kotkansalo · University of Turku

Pauliina Kronqvist · University of Turku

Yrjö Collan · University of Turku

Abstract

We have found a 'wrong positive' Ki67 group with favourable prognosis. SMI cannot be replaced by Ki67 because of the danger of misclassification of some patients.

Topics & Keywords

Cancer Genomics and Diagnostics Breast Lesions and Carcinomas Pancreatic and Hepatic Oncology Research

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Histopathology

Volume 48, Issue 6, pp. 674-682

DOI: 10.1111/j.1365-2559.2006.02402.x

Field-Weighted Citation Impact: 3.43